Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Omitting of Lymphadenectomy is Acceptable for Lung Cancer Smaller Than 6 mm in Solid Size

NCT06516796 is registered in ClinicalTrials.gov with Liang Chen as lead sponsor.

NCT NCT06516796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06516796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Omitting of Lymphadenectomy is Acceptable for Lung Cancer Smaller Than 6 mm in Solid Size
Lead sponsor
Liang Chen
Phase
Observational
Overall status
Completed
Start date
January 1, 2023
Completion date
February 1, 2024
Enrollment
2,713 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer